首页 > 最新文献

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology最新文献

英文 中文
Method Development and Validation of Lorlatinib by RP-HPLC. 采用 RP-HPLC 法开发和验证洛拉替尼(Lorlatinib)的方法。
Santhosh Illendula, Shailesh Sharma

A simple, Accurate, precise method was developed for the estimation of the Lorlatinib in API form and Marketed pharmaceutical dosage form by RP-HPLC. Chromatogram was run through Hypersil C18 (4.6mm×150mm, 5µm) Particle size Column and Mobile phase containing Methanol and Water taken in the ratio of 25: 75% v/v was pumped through column at a flow rate of 1.0 ml/min. Temperature was maintained at 38ºC. Optimized wavelength selected was 310 nm. Retention times of Lorlatinib were found to be 3.513 minutes respectively. The %RSD for the Repeatability and Intermediate Precision of the Lorlatinib were found to be within limits. %Recovery was obtained 98.96% and it was found to be within the limits for Lorlatinib respectively. The LOD, LOQ values obtained from regression equations of Lorlatinib were 0.332µg/ml and 1.0078 µg/ml respectively. Regression equation of Lorlatinib was found to be y = 39948x + 16821 respectively. The Retention times was decreased and run time was decreased, so the method developed was simple and economical that can be adopted in regular Quality control test in Industries.

采用 RP-HPLC 法测定原料药和上市药品剂型中的氯拉替尼,该方法简单、准确、精密。色谱柱为 Hypersil C18(4.6mm×150mm,5µm),流动相为甲醇和水,流速为 1.0 ml/min。温度保持在 38ºC。选择的最佳波长为 310 nm。洛拉替尼的保留时间分别为 3.513 分钟。洛拉替尼的重复性和中间精密度的 RSD%均在限值之内。洛拉替尼的回收率为 98.96%,在限值范围内。洛拉替尼的回归方程得出的最低检测限和最低定量限分别为 0.332 微克/毫升和 1.0078 微克/毫升。洛拉替尼的回归方程分别为 y = 39948x + 16821。保留时间缩短,运行时间减少,因此所开发的方法简单经济,可用于工业中的常规质量控制测试。
{"title":"Method Development and Validation of Lorlatinib by RP-HPLC.","authors":"Santhosh Illendula, Shailesh Sharma","doi":"10.62958/j.cjap.2024.009","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.009","url":null,"abstract":"<p><p>A simple, Accurate, precise method was developed for the estimation of the Lorlatinib in API form and Marketed pharmaceutical dosage form by RP-HPLC. Chromatogram was run through Hypersil C18 (4.6mm×150mm, 5µm) Particle size Column and Mobile phase containing Methanol and Water taken in the ratio of 25: 75% v/v was pumped through column at a flow rate of 1.0 ml/min. Temperature was maintained at 38ºC. Optimized wavelength selected was 310 nm. Retention times of Lorlatinib were found to be 3.513 minutes respectively. The %RSD for the Repeatability and Intermediate Precision of the Lorlatinib were found to be within limits. %Recovery was obtained 98.96% and it was found to be within the limits for Lorlatinib respectively. The LOD, LOQ values obtained from regression equations of Lorlatinib were 0.332µg/ml and 1.0078 µg/ml respectively. Regression equation of Lorlatinib was found to be y = 39948x + 16821 respectively. The Retention times was decreased and run time was decreased, so the method developed was simple and economical that can be adopted in regular Quality control test in Industries.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240009"},"PeriodicalIF":0.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142005478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statistical Design Approach for the Formulation And Optimization of Nanosponges Using Poorly Water-soluble Candidate. 使用水溶性差的候选物质配制和优化纳米海绵的统计设计方法
Ritu Verma, Pranshul Sethi, Sonali Rastogi, Vinayak Sahebrao Mundhe, Rajesh Ks, Saurabh Mishra, Mayur Rajendra Bhurat, Prasanthi Samathoti

Background and objectives: Nanosponges are one of the most innovative ways to use the newest developments in nanodrugs delivery. Nanosponges can catch drugs that dissolve in water or ones that don't. This work uses statistical design to find the best nanosponges for drugs that don't dissolve easily and make them.

Material and methods: It was looked into how to statistically make the most of the effects of independent factors. The ethyl cellulose ratio and stirring rate were chosen based on how they affected the dependent variables, such as particle size and how well they were trapped. FTIR, SEM, zeta potential, entrapment efficiency, and particle size data were used to test the nanosponges that were made. Using carbopol, the best lot of nanosponges was added to the gel.

Results: Using ethyl cellulose and polyvinyl alcohol as stabilizers in the emulsion liquid diffusion method, it was possible to make drug-loaded nanosponges. It was possible to make the nanosponges composition work better by using Central Composite Design. It has been seen that making drug-filled nanosponges improves stability.

Conclusion: The study showcased the enhanced capacity of a formulation with decreased particle size and high entrapment efficiency to disseminate effectively.

背景和目的:纳米海绵是利用纳米药物递送最新技术的最具创新性的方法之一。纳米海绵可以捕捉溶于水的药物,也可以捕捉不溶于水的药物。这项工作利用统计学设计,为不易溶解的药物找到最佳纳米海绵,并将其制成纳米海绵:研究了如何从统计学角度最大限度地利用独立因素的影响。选择乙基纤维素比例和搅拌速率的依据是它们对因变量的影响,如颗粒大小和截留效果。傅立叶变换红外光谱、扫描电子显微镜、ZETA电位、捕获效率和粒度数据被用来测试制作的纳米海绵。结果显示,使用carbopol制成的纳米海绵添加到凝胶中的效果最好:结果:在乳液扩散法中使用乙基纤维素和聚乙烯醇作为稳定剂,可以制成载药纳米海绵。利用中心复合设计可以使纳米海绵成分更好地发挥作用。可以看出,制作药物填充纳米海绵提高了稳定性:该研究表明,粒径减小、夹带效率高的配方可提高有效传播能力。
{"title":"Statistical Design Approach for the Formulation And Optimization of Nanosponges Using Poorly Water-soluble Candidate.","authors":"Ritu Verma, Pranshul Sethi, Sonali Rastogi, Vinayak Sahebrao Mundhe, Rajesh Ks, Saurabh Mishra, Mayur Rajendra Bhurat, Prasanthi Samathoti","doi":"10.62958/j.cjap.2024.021","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.021","url":null,"abstract":"<p><strong>Background and objectives: </strong>Nanosponges are one of the most innovative ways to use the newest developments in nanodrugs delivery. Nanosponges can catch drugs that dissolve in water or ones that don't. This work uses statistical design to find the best nanosponges for drugs that don't dissolve easily and make them.</p><p><strong>Material and methods: </strong>It was looked into how to statistically make the most of the effects of independent factors. The ethyl cellulose ratio and stirring rate were chosen based on how they affected the dependent variables, such as particle size and how well they were trapped. FTIR, SEM, zeta potential, entrapment efficiency, and particle size data were used to test the nanosponges that were made. Using carbopol, the best lot of nanosponges was added to the gel.</p><p><strong>Results: </strong>Using ethyl cellulose and polyvinyl alcohol as stabilizers in the emulsion liquid diffusion method, it was possible to make drug-loaded nanosponges. It was possible to make the nanosponges composition work better by using Central Composite Design. It has been seen that making drug-filled nanosponges improves stability.</p><p><strong>Conclusion: </strong>The study showcased the enhanced capacity of a formulation with decreased particle size and high entrapment efficiency to disseminate effectively.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240021"},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141989069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stability Development, Optimization and Evaluation of Gastro-Retentive Microspheres of Antidiabetic Agent by Full Factorial Design. 通过全因子设计开发、优化和评估抗糖尿病药胃滞留微球的稳定性
Yogesh Baburao Raut, Kalyan Chakravarthy Janjanam, Trinayan Deka, Vijay Gajananrao Thakare, Pramod Khobragade, Arul Prakasam K C, Ravindra Chandrakant Sutar, Rahul L Shirole

Objective: This work is aimed to Formulate, Optimize and Evaluate Gastro-Retentive Microspheres of Antidiabetic Agent by Full Factorial Design.

Methods: Microspheres were prepared using Emulsification-cross linking technique. To this HPMC-K4M and Carbopol was dissolved in 250 ml of water and allowed to swell for 24 hr at room temperature. And separately chitosan was dissolved in 3% (v/v) glacial acetic acid and this also kept for 24 h to swell or dissolve properly. After 24hr this swelled mixture was mixed under magnetic stirrer (Remi, India) at specific stirring rate for 1hr in order to find homogeneous mass of both the gum. Then slurry of chitosan also was homogenized for half an hour. The drug, Glipizide (1g) was then added to the chitosan solution and mixed homogenesously.

Results: The aim of the study was to formulate and evaluate microspheres, for Gastro-Retentive Microspheres of the chosen drug. The EE of microspheres was found to be 91.52%, maximum . Buoyancy property observed was 93.82% for Optimized formulation F-9, Drug release 57.34% till 8 h. The work also aims to study various parameters affecting the behaviour of microspheres in oral dosage form.

Conclusion: Drugs with short half-life that are absorbed from the gastrointestinal tract (GIT) are eliminated rapidly from the blood flow. To avoid this, the oral SR Gastro-retentive was developed as this formulation released the drug slowly into the GIT and maintained a stable drug concentration in the serum for a longer duration of time.

目的本研究旨在通过全因子设计法配制、优化和评估抗糖尿病药物的胃肠黏附微球:方法:采用乳化-交联技术制备微球。将 HPMC-K4M 和 Carbopol 溶于 250 毫升水中,在室温下膨胀 24 小时。另外,将壳聚糖溶解在 3%(体积分数)的冰醋酸中,同样放置 24 小时,使其充分溶解或膨胀。24 小时后,在磁力搅拌器(Remi,印度)上以特定的搅拌速度混合这种膨胀的混合物 1 小时,以找到两种胶的均匀质量。然后,壳聚糖浆也被均质半小时。然后将药物格列吡嗪(1 克)加入壳聚糖溶液中并混合均匀:研究的目的是配制和评估微球,用于所选药物的胃滞留微球。结果发现,微球的 EE 为 91.52%,达到最大值。优化配方 F-9 的浮力特性为 93.82%,8 小时内药物释放率为 57.34%。这项工作还旨在研究影响口服剂型微球行为的各种参数:结论:半衰期短的药物从胃肠道(GIT)吸收后会迅速从血液中排出。为了避免这种情况,我们开发了口服 SR Gastro-retentive,因为这种制剂能缓慢地将药物释放到胃肠道,并在较长时间内保持血清中药物浓度的稳定。
{"title":"Stability Development, Optimization and Evaluation of Gastro-Retentive Microspheres of Antidiabetic Agent by Full Factorial Design.","authors":"Yogesh Baburao Raut, Kalyan Chakravarthy Janjanam, Trinayan Deka, Vijay Gajananrao Thakare, Pramod Khobragade, Arul Prakasam K C, Ravindra Chandrakant Sutar, Rahul L Shirole","doi":"10.62958/j.cjap.2024.019","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.019","url":null,"abstract":"<p><strong>Objective: </strong>This work is aimed to Formulate, Optimize and Evaluate Gastro-Retentive Microspheres of Antidiabetic Agent by Full Factorial Design.</p><p><strong>Methods: </strong>Microspheres were prepared using Emulsification-cross linking technique. To this HPMC-K4M and Carbopol was dissolved in 250 ml of water and allowed to swell for 24 hr at room temperature. And separately chitosan was dissolved in 3% (v/v) glacial acetic acid and this also kept for 24 h to swell or dissolve properly. After 24hr this swelled mixture was mixed under magnetic stirrer (Remi, India) at specific stirring rate for 1hr in order to find homogeneous mass of both the gum. Then slurry of chitosan also was homogenized for half an hour. The drug, Glipizide (1g) was then added to the chitosan solution and mixed homogenesously.</p><p><strong>Results: </strong>The aim of the study was to formulate and evaluate microspheres, for Gastro-Retentive Microspheres of the chosen drug. The EE of microspheres was found to be 91.52%, maximum . Buoyancy property observed was 93.82% for Optimized formulation F-9, Drug release 57.34% till 8 h. The work also aims to study various parameters affecting the behaviour of microspheres in oral dosage form.</p><p><strong>Conclusion: </strong>Drugs with short half-life that are absorbed from the gastrointestinal tract (GIT) are eliminated rapidly from the blood flow. To avoid this, the oral SR Gastro-retentive was developed as this formulation released the drug slowly into the GIT and maintained a stable drug concentration in the serum for a longer duration of time.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240019"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stability Indicating UPLC Method Development and Validation for the Quantitative Estimation of Pazopanib in Pure form and Marketed Pharmaceutical Dosage form. 用于帕唑帕尼纯制剂和上市药品剂型定量估算的稳定性指示 UPLC 方法开发与验证
Nerella Naveen Kumar, Shailesh Sharma

An analytical, accurate, precise, specific, efficient and simple Ultra-Performance Liquid Chromatography method has been developed and validated for the determination of Pazopanib in bulk and was applied on marketed Pharmaceutical Dosage form. The mobile phase used for the chromatographic runs consisted of 0.1% OPA Buffer and Acetonitrile in the ratio of 30:70% v/v. The separation was achieved on a BHEL UPLC column using isocratic mode. Pazopanib Drug peak were well separated and were detected by a PDA detector at 256 nm. The developed method was linear at the concentration range 6-14 μg/ml for Pazopanib. The method has been validated according to ICH guidelines with respect to system suitability, specificity, precision, accuracy and robustness. The LOD and LOQ for the Pazopanib were found to be 0.5853 µg/ml and 1.7738µg/ml respectively. The developed method is simple, precise, specific, accurate and rapid, making it suitable for estimation of Pazopanib in bulk and marketed pharmaceutical dosage form dosage form.

本研究建立并验证了一种分析、准确、精确、特异、高效和简便的超高效液相色谱法,用于测定散装帕唑帕尼并将其应用于市场上的药物剂型。色谱流动相为 0.1% OPA 缓冲溶液和乙腈,体积比为 30:70%。在 BHEL UPLC 色谱柱上以等度模式进行分离。帕唑帕尼药物峰分离良好,采用PDA检测器在256 nm波长下检测。所建立的方法在帕唑帕尼 6-14 μg/ml 浓度范围内线性关系良好。该方法的系统适用性、特异性、精密度、准确度和稳健性均符合ICH指南的要求。帕唑帕尼的检出限(LOD)和定量限(LOQ)分别为 0.5853µg/ml 和 1.7738µg/ml。该方法简便、精确、特异、准确、快速,适用于帕唑帕尼散剂和市场上销售的药物剂型的检测。
{"title":"Stability Indicating UPLC Method Development and Validation for the Quantitative Estimation of Pazopanib in Pure form and Marketed Pharmaceutical Dosage form.","authors":"Nerella Naveen Kumar, Shailesh Sharma","doi":"10.62958/j.cjap.2024.018","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.018","url":null,"abstract":"<p><p>An analytical, accurate, precise, specific, efficient and simple Ultra-Performance Liquid Chromatography method has been developed and validated for the determination of Pazopanib in bulk and was applied on marketed Pharmaceutical Dosage form. The mobile phase used for the chromatographic runs consisted of 0.1% OPA Buffer and Acetonitrile in the ratio of 30:70% v/v. The separation was achieved on a BHEL UPLC column using isocratic mode. Pazopanib Drug peak were well separated and were detected by a PDA detector at 256 nm. The developed method was linear at the concentration range 6-14 μg/ml for Pazopanib. The method has been validated according to ICH guidelines with respect to system suitability, specificity, precision, accuracy and robustness. The LOD and LOQ for the Pazopanib were found to be 0.5853 µg/ml and 1.7738µg/ml respectively. The developed method is simple, precise, specific, accurate and rapid, making it suitable for estimation of Pazopanib in bulk and marketed pharmaceutical dosage form dosage form.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240018"},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141894501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Synergistic Activity of Ethanolic Leaf Extracts of Tephrosia Purpurea and Bacopa Monnieri in Ulcer Induced Rats. 评估紫苏叶乙醇提取物和百部的协同作用对溃疡诱导大鼠的影响
Ponnala Soumya, Suvendu Saha, Saketha Ram Palakurthy, Ravalya Pasupluleti

Objective: To evaluate synergistic antiulcer activity of ethanolic extracts of Tephrosia purpurea and Bacopa monnieri in ulcer induced rats.

Methods: Ethanolic leaf extracts of both the plants were administered individually and in combination at a dose of 200mg/kg to ulcer induced male albino rats. Omeprazole 10mg/kg was used as standard. Pylorus ligation method, ethanol and indomethacin induced gastric ulcer models were the different gastric ulcer models selected for the induction of ulcer in rats. Ulcer index, ulcer score, total acidity, pH, percentage protection, volume of gastric juice were the parameters evaluated and compared in different groups in all the models.

Results: Decrease in the ulcer score, ulcer index, total acidity was observed and percentage protection was significant(*p<0.05 and p<0.01) with the combination extract compared to group received individual plant extracts.

Conclusion: Our results suggested that combination of two medicinal plants showed synergistic anti ulcer activity and decreased the formation of ulcer lesions in rats.

目的评估紫锥菊和百部的乙醇提取物对溃疡诱导大鼠的协同抗溃疡活性:对诱发溃疡的雄性白化大鼠单独或联合施用这两种植物的乙醇叶提取物,剂量为 200 毫克/千克。奥美拉唑 10 毫克/千克用作标准剂量。幽门结扎法、乙醇和吲哚美辛诱导的胃溃疡模型是诱导大鼠溃疡的不同胃溃疡模型。在所有模型中,溃疡指数、溃疡评分、总酸度、pH 值、保护率、胃液量是评估和比较不同组别的参数:结果:观察到溃疡评分、溃疡指数、总酸度降低,保护率显著降低(*p):我们的研究结果表明,两种药用植物的组合具有协同抗溃疡活性,能减少大鼠溃疡病变的形成。
{"title":"Evaluation of Synergistic Activity of Ethanolic Leaf Extracts of Tephrosia Purpurea and Bacopa Monnieri in Ulcer Induced Rats.","authors":"Ponnala Soumya, Suvendu Saha, Saketha Ram Palakurthy, Ravalya Pasupluleti","doi":"10.62958/j.cjap.2024.015","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.015","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate synergistic antiulcer activity of ethanolic extracts of Tephrosia purpurea and Bacopa monnieri in ulcer induced rats.</p><p><strong>Methods: </strong>Ethanolic leaf extracts of both the plants were administered individually and in combination at a dose of 200mg/kg to ulcer induced male albino rats. Omeprazole 10mg/kg was used as standard. Pylorus ligation method, ethanol and indomethacin induced gastric ulcer models were the different gastric ulcer models selected for the induction of ulcer in rats. Ulcer index, ulcer score, total acidity, pH, percentage protection, volume of gastric juice were the parameters evaluated and compared in different groups in all the models.</p><p><strong>Results: </strong>Decrease in the ulcer score, ulcer index, total acidity was observed and percentage protection was significant(*p<0.05 and p<0.01) with the combination extract compared to group received individual plant extracts.</p><p><strong>Conclusion: </strong>Our results suggested that combination of two medicinal plants showed synergistic anti ulcer activity and decreased the formation of ulcer lesions in rats.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240015"},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation Development, Optimization and Evaluation of Flurbiprofen Microsponge Tablet for the Treatment of Rheumatoid Arthritis (RA) by using Box- Behnken Design. 采用方框贝肯设计开发、优化和评估用于治疗类风湿性关节炎(RA)的氟比洛芬微海绵片的配方
Muthadi Radhika Reddy, Madhavi Latha Samala, Narahari Kv, J K Shyamala, Parag Kulkarni, Bhargav Gunnepalli, Prasanthi Boddu, T Naga Aparna

Introduction: Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory disease that mostly impacts the joints. Chronotherapeutics refers to a treatment method in which in-vivo drug availability is timed to match rhythms of disease in order to optimize therapeutic outcomes and minimize side effects. Flurbiprofen is a non-steroidal anti-inflammatory drug, indicated for the relief of inflammation.

Objectives: The aim of the present study was to develop & optimize the microsponges based of Flurbiprofen tablet for Chronotherapeutics for enhanced therapeutic effect.

Methods: Microsponges were developed by Quasi Emulsion solvent diffusion method. Prepared microsponges were optimized in order to analyze the effects of independent variables like concentration of PVA (X1), Volume of Dichloromethane (X2) & stirring speed (X3) on the Entrapment Efficiency (Y1), Mean particle size (Y2) and Drug release at 8 hr (Y3) using box Behnken design. The optimized formulation was subjected to in vitro study and Comparison with marketed formulation. With release kinetics study.

Result: The optimized formulation Batch (F-18) Show particle size of 49.12µm, entrapment efficiency of 87.46%, and drug release at 8 h 70.49%, which is under the acceptance criteria, which is more effective compared with Marketed tablet.

Conclusion: The results showed that, as stirring speed increases, the particle size decreases and entrapment efficiency increases. While volume of dichloromethane increases, particle size decreases. Morphology was found to be porous and spherical. Optimized batch of Flurbiprofen microsponge was further formulated in future for invivo study and clinical trials.

导言类风湿性关节炎(RA)是一种主要影响关节的慢性自身免疫性炎症疾病。慢性治疗学是指一种治疗方法,根据疾病的节律调整体内药物的供应时间,以优化治疗效果并减少副作用。氟比洛芬是一种非甾体抗炎药,适用于缓解炎症:本研究旨在开发和优化用于慢性治疗的氟比洛芬片的微海绵,以提高治疗效果:方法:采用准乳液溶剂扩散法研制微海绵。方法:采用准乳液溶剂扩散法制备微海绵,并利用盒式贝肯设计对制备的微海绵进行优化,以分析 PVA 浓度(X1)、二氯甲烷体积(X2)和搅拌速度(X3)等自变量对包封效率(Y1)、平均粒径(Y2)和 8 小时药物释放量(Y3)的影响。对优化后的制剂进行了体外研究,并与市场上销售的制剂进行了比较。结果:结果:优化配方批次(F-18)的粒度为 49.12µm,夹带效率为 87.46%,8 小时药物释放率为 70.49%,均在接受标准范围内,与市售片剂相比更有效:结果表明,随着搅拌速度的增加,粒度减小,夹带效率增加。随着二氯甲烷体积的增加,粒径减小。形态为多孔球形。优化后的氟比洛芬微海绵将进一步用于体内研究和临床试验。
{"title":"Formulation Development, Optimization and Evaluation of Flurbiprofen Microsponge Tablet for the Treatment of Rheumatoid Arthritis (RA) by using Box- Behnken Design.","authors":"Muthadi Radhika Reddy, Madhavi Latha Samala, Narahari Kv, J K Shyamala, Parag Kulkarni, Bhargav Gunnepalli, Prasanthi Boddu, T Naga Aparna","doi":"10.62958/j.cjap.2024.016","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.016","url":null,"abstract":"<p><strong>Introduction: </strong>Rheumatoid arthritis (RA) is a chronic, autoimmune and inflammatory disease that mostly impacts the joints. Chronotherapeutics refers to a treatment method in which in-vivo drug availability is timed to match rhythms of disease in order to optimize therapeutic outcomes and minimize side effects. Flurbiprofen is a non-steroidal anti-inflammatory drug, indicated for the relief of inflammation.</p><p><strong>Objectives: </strong>The aim of the present study was to develop & optimize the microsponges based of Flurbiprofen tablet for Chronotherapeutics for enhanced therapeutic effect.</p><p><strong>Methods: </strong>Microsponges were developed by Quasi Emulsion solvent diffusion method. Prepared microsponges were optimized in order to analyze the effects of independent variables like concentration of PVA (X1), Volume of Dichloromethane (X2) & stirring speed (X3) on the Entrapment Efficiency (Y1), Mean particle size (Y2) and Drug release at 8 hr (Y3) using box Behnken design. The optimized formulation was subjected to in vitro study and Comparison with marketed formulation. With release kinetics study.</p><p><strong>Result: </strong>The optimized formulation Batch (F-18) Show particle size of 49.12µm, entrapment efficiency of 87.46%, and drug release at 8 h 70.49%, which is under the acceptance criteria, which is more effective compared with Marketed tablet.</p><p><strong>Conclusion: </strong>The results showed that, as stirring speed increases, the particle size decreases and entrapment efficiency increases. While volume of dichloromethane increases, particle size decreases. Morphology was found to be porous and spherical. Optimized batch of Flurbiprofen microsponge was further formulated in future for invivo study and clinical trials.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240016"},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Antioxidant and Antimicrobial Activity of Ethanolic Extract of Medicinal Plants Baccaurea Ramiflora and Microcos Paniculata. 药用植物 Baccaurea Ramiflora 和 Microcos Paniculata 乙醇提取物的抗氧化和抗菌活性评估。
Suvendu Saha, T Shivaraj Gouda, Arunabha Mallik

Objective: The present study was undertaken to investigate the antioxidant and antimicrobial effect of ethanolic leaf extract of Baccaurea ramiflora and Microcos paniculata.

Methods: DPPH radical scavenging activity, Nitric oxide scavenging activity, Super oxide anion radical scavenging activity, Reducing power assay were used to assess antioxidant efficacy. Zone of Inhibition determination by Agar well diffusion assay was used to assess antimicrobial activity.

Results: The Baccaurea ramiflora and Microcos paniculata leaves extracted with different solvents such as petroleum ether, chloroform, ethanol and water among that in leaves ethanolic extract produce 10.78, 10.38 percentage yield respectively. Both the extracts subjected for phytochemical investigation revealed the presence of alkaloids, glycosides, tannins, saponins, proteins and flavonoids. Ethanolic extract of Baccaurea ramiflora showed maximum inhibition zone diameter was obtained in Salmonella typhi (Gram-negative bacteria) with diameter 29 mm and 25 mm respectively at 200mg/ml and 100mg/ml. Similarly, Ethanolic extract of Microcos paniculata showed minimum inhibition zone diameter compare to Baccaurea ramiflora was obtained in Salmonella typhi (Gram-negative bacteria) with diameter 23 mm and 19 mm respectively at 200mg/ml and 100mg/ml. Ethanolic extract of Baccaurea ramiflora showed maximum inhibition zone diameter was obtained in Aspergillus fumigates with diameter 25 mm and 22 mm respectively at 200mg/ml and 100mg/ml. Similarly, Ethanolic extract of Microcos paniculata showed minimum inhibition zone diameter compare to Baccaurea ramiflora was obtained in Aspergillus fumigates with diameter 21 mm and 19 mm respectively at 200mg/ml and 100mg/ml.

Conclusion: The current findings point to Baccaurea ramiflora and Microcos paniculata antioxidant and antimicrobial properties. However future studies should be designed to isolate the active constituents responsible for the specified effect.

研究目的本研究旨在调查苧麻和堇菜乙醇叶提取物的抗氧化和抗菌效果:方法:采用 DPPH 自由基清除活性、一氧化氮清除活性、超氧化物阴离子自由基清除活性和还原力测定法评估抗氧化功效。采用琼脂井扩散法测定抑菌区,以评估抗菌活性:结果:用石油醚、氯仿、乙醇和水等不同溶剂萃取的苎麻叶和堇菜叶的乙醇提取物的得率分别为 10.78%和 10.38%。对两种提取物进行的植物化学调查显示,其中都含有生物碱、苷、单宁、皂甙、蛋白质和黄酮类化合物。苧麻乙醇提取物对伤寒沙门氏菌(革兰氏阴性菌)的最大抑菌区直径分别为 29 毫米和 25 毫米,浓度分别为 200 毫克/毫升和 100 毫克/毫升。同样,在 200 毫克/毫升和 100 毫克/毫升的浓度下,微囊藻乙醇提取物对伤寒沙门氏菌(革兰氏阴性菌)的抑制区直径最小,分别为 23 毫米和 19 毫米。在 200 毫克/毫升和 100 毫克/毫升的浓度下,苧麻乙醇提取物对熏曲霉的最大抑制区直径分别为 25 毫米和 22 毫米。同样,在 200 毫克/毫升和 100 毫克/毫升的浓度下,微囊藻乙醇提取物对熏曲霉的抑制区直径最小,分别为 21 毫米和 19 毫米:目前的研究结果表明,苧麻和穇子草具有抗氧化和抗菌特性。不过,今后的研究应旨在分离出产生特定效果的活性成分。
{"title":"Evaluation of Antioxidant and Antimicrobial Activity of Ethanolic Extract of Medicinal Plants Baccaurea Ramiflora and Microcos Paniculata.","authors":"Suvendu Saha, T Shivaraj Gouda, Arunabha Mallik","doi":"10.62958/j.cjap.2024.014","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.014","url":null,"abstract":"<p><strong>Objective: </strong>The present study was undertaken to investigate the antioxidant and antimicrobial effect of ethanolic leaf extract of Baccaurea ramiflora and Microcos paniculata.</p><p><strong>Methods: </strong>DPPH radical scavenging activity, Nitric oxide scavenging activity, Super oxide anion radical scavenging activity, Reducing power assay were used to assess antioxidant efficacy. Zone of Inhibition determination by Agar well diffusion assay was used to assess antimicrobial activity.</p><p><strong>Results: </strong>The Baccaurea ramiflora and Microcos paniculata leaves extracted with different solvents such as petroleum ether, chloroform, ethanol and water among that in leaves ethanolic extract produce 10.78, 10.38 percentage yield respectively. Both the extracts subjected for phytochemical investigation revealed the presence of alkaloids, glycosides, tannins, saponins, proteins and flavonoids. Ethanolic extract of Baccaurea ramiflora showed maximum inhibition zone diameter was obtained in Salmonella typhi (Gram-negative bacteria) with diameter 29 mm and 25 mm respectively at 200mg/ml and 100mg/ml. Similarly, Ethanolic extract of Microcos paniculata showed minimum inhibition zone diameter compare to Baccaurea ramiflora was obtained in Salmonella typhi (Gram-negative bacteria) with diameter 23 mm and 19 mm respectively at 200mg/ml and 100mg/ml. Ethanolic extract of Baccaurea ramiflora showed maximum inhibition zone diameter was obtained in Aspergillus fumigates with diameter 25 mm and 22 mm respectively at 200mg/ml and 100mg/ml. Similarly, Ethanolic extract of Microcos paniculata showed minimum inhibition zone diameter compare to Baccaurea ramiflora was obtained in Aspergillus fumigates with diameter 21 mm and 19 mm respectively at 200mg/ml and 100mg/ml.</p><p><strong>Conclusion: </strong>The current findings point to Baccaurea ramiflora and Microcos paniculata antioxidant and antimicrobial properties. However future studies should be designed to isolate the active constituents responsible for the specified effect.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240014"},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development, Optimization and Evaluation of Mucoadhesive Microspheres of Amoxicillin for the Treatment of H.Pylori by Full Factorial Design. 通过全因子设计开发、优化和评估用于治疗幽门螺杆菌的阿莫西林黏胶微球
Bhawna Sharma, Anand Chaurasia, Naveen Gupta, Dharmendra Singh Rajput

Objective: This work is aimed to formulate and evaluate Mucoadhesive Microspheres contain Amoxicillin for the effective use in the treatment of H.Pylori.

Methods: Microspheres were prepared using Emulsification-cross linking technique. To this guar gum (GG) and sodium alginate (SA) was dissolved in 200 ml of water and allowed to swell for 24 h at room temperature. And separately chitosan (CH) was dissolved in 2% (v/v) glacial acetic acid and this also kept for 24 h to swell or dissolve properly. After 24 h this swelled mixture was mixed under magnetic stirrer (Remi, India) at specific stirring rate for 1 h in order to find homogeneous mass of both the gum. Then slurry of chitosan also was homogenized for half an hour. The drug, Amoxicillin (1g) was then added to the chitosan solution and mixed homogeneously.

Results: The aim of the study was to formulate and evaluate microspheres, for SR of the chosen drug. The particle size of microspheres was in the range of 200-500 µ, maximum mucoadhesive property observed was 57.41% for Optimized formulation F-9, Drug release 68.52% till 8 h, and the maximum entrapment was 94.87% for F-9 formulation. The work also aims to study various parameters affecting the behavior of microspheres in oral dosage form.

Conclusion: Drugs with short half life that are absorbed from the gastrointestinal tract (GIT) are eliminated rapidly from the blood flow. To avoid this, the oral SR was developed as this formulation released the drug slowly into the GIT and maintained a stable drug concentration in the serum for a longer duration of time.

目的本研究旨在配制和评估含有阿莫西林的黏附性微球,以有效治疗幽门螺杆菌:方法:采用乳化-交联技术制备微球。将瓜尔胶(GG)和海藻酸钠(SA)溶于 200 毫升水中,在室温下放置 24 小时。另外,将壳聚糖(CH)溶于 2%(v/v)的冰醋酸中,同样放置 24 小时使其充分溶解或膨胀。24 小时后,在磁力搅拌器(Remi,印度)上以特定的搅拌速度混合这种膨胀的混合物 1 小时,以找到两种胶的均匀质量。然后,壳聚糖浆也被均质半小时。然后将药物阿莫西林(1 克)加入壳聚糖溶液并混合均匀:研究的目的是配制和评估微球,用于所选药物的 SR。微球的粒径在 200-500 µ 之间,优化配方 F-9 的粘附性最大为 57.41%,8 小时内的药物释放率为 68.52%,F-9 配方的最大夹持率为 94.87%。这项工作还旨在研究影响口服剂型微球行为的各种参数:半衰期短的药物从胃肠道(GIT)吸收后会迅速从血液中排出。为了避免这种情况,我们开发了口服 SR,因为这种制剂能缓慢地将药物释放到胃肠道,并在较长时间内保持血清中药物浓度的稳定。
{"title":"Development, Optimization and Evaluation of Mucoadhesive Microspheres of Amoxicillin for the Treatment of H.Pylori by Full Factorial Design.","authors":"Bhawna Sharma, Anand Chaurasia, Naveen Gupta, Dharmendra Singh Rajput","doi":"10.62958/j.cjap.2024.017","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.017","url":null,"abstract":"<p><strong>Objective: </strong>This work is aimed to formulate and evaluate Mucoadhesive Microspheres contain Amoxicillin for the effective use in the treatment of H.Pylori.</p><p><strong>Methods: </strong>Microspheres were prepared using Emulsification-cross linking technique. To this guar gum (GG) and sodium alginate (SA) was dissolved in 200 ml of water and allowed to swell for 24 h at room temperature. And separately chitosan (CH) was dissolved in 2% (v/v) glacial acetic acid and this also kept for 24 h to swell or dissolve properly. After 24 h this swelled mixture was mixed under magnetic stirrer (Remi, India) at specific stirring rate for 1 h in order to find homogeneous mass of both the gum. Then slurry of chitosan also was homogenized for half an hour. The drug, Amoxicillin (1g) was then added to the chitosan solution and mixed homogeneously.</p><p><strong>Results: </strong>The aim of the study was to formulate and evaluate microspheres, for SR of the chosen drug. The particle size of microspheres was in the range of 200-500 µ, maximum mucoadhesive property observed was 57.41% for Optimized formulation F-9, Drug release 68.52% till 8 h, and the maximum entrapment was 94.87% for F-9 formulation. The work also aims to study various parameters affecting the behavior of microspheres in oral dosage form.</p><p><strong>Conclusion: </strong>Drugs with short half life that are absorbed from the gastrointestinal tract (GIT) are eliminated rapidly from the blood flow. To avoid this, the oral SR was developed as this formulation released the drug slowly into the GIT and maintained a stable drug concentration in the serum for a longer duration of time.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240017"},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood Transfusion Reaction Reporting at a Tertiary Care Hospital: A Cross Sectional Study.
Kavi Manasa, Gurudutta Pattnaik, Y Madhusudan Rao, SaratKumar Behera, Amulyaratna Behera

Background: Blood transfusion is the infusion of whole blood or its components into the veins of the patient to improve tissue oxygenation and maintain hemostasis. Besides its clinical use, it can pose a risk of transfusion complications with different factors.

Purpose: The aim of this study was to assess blood transfusion complications, and associated factors among transfused adult patients at Tertiary care Hospital, Hyderabad, 2022.

Materials and methods: An institution-based cross-sectional study design was conducted on a total of 182 patients from March 20 to June 15, 2022. Patients were enrolled in the study using consecutive sampling method. The socio-demographic and clinical data were collected using a structured questionnaire and data extraction sheet, respectively. About 3 ml of anti-coagulated blood and 30 ml of urine samples were collected to assess transfusion complications. CBC and Coombs test were performed from blood and urinalysis from urine, respectively. Chi-square, Fisher's exact test, and binary logistic regression were done using SPSS version 25. P-values less than 0.05 are declared as statistically significant.

Results: An acute transfusion reaction (ATR) was encountered in 12 (6.6%) patients. It was 4.13, 7.78 and 3.96 times more likely to occur among patients with a previous history of transfusion, abortion, and transfused blood stored for more than 20 days compared to their counterparts, respectively. In addition, the odds of developing ATR increase by 2.07 as the number of transfused blood units increases by 1 unit.

Conclusion: The incidence of acute transfusion reactions was high. During transfusion, clinicians should closely monitor patients who had history of transfusion, abortion, transfused old blood and more than 1 unit.

背景:输血是将全血或其成分注入患者静脉,以改善组织氧合和维持止血。目的:本研究旨在评估 2022 年海德拉巴市三级医院输血成人患者的输血并发症及相关因素:从 2022 年 3 月 20 日至 6 月 15 日,共对 182 名患者进行了基于医院的横断面研究设计。患者采用连续抽样法入组。社会人口学和临床数据分别通过结构化问卷和数据提取表收集。收集了约 3 毫升抗凝血和 30 毫升尿液样本,以评估输血并发症。分别对血液和尿液进行了全血细胞计数和库姆斯氏试验。使用 SPSS 25 版进行了卡方检验、费雪精确检验和二元逻辑回归。P值小于0.05为有统计学意义:结果:12 名患者(6.6%)出现了急性输血反应(ATR)。与同类患者相比,既往有输血史、流产史和输血储存超过 20 天的患者发生急性输血反应的几率分别高出 4.13 倍、7.78 倍和 3.96 倍。此外,输血量每增加一个单位,发生急性输血反应的几率就会增加 2.07 倍:结论:急性输血反应的发生率很高。结论:急性输血反应的发生率很高,在输血过程中,临床医生应密切监测有输血史、流产、输注过期血液和超过 1 个单位的患者。
{"title":"Blood Transfusion Reaction Reporting at a Tertiary Care Hospital: A Cross Sectional Study.","authors":"Kavi Manasa, Gurudutta Pattnaik, Y Madhusudan Rao, SaratKumar Behera, Amulyaratna Behera","doi":"10.62958/j.cjap.2024.013","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.013","url":null,"abstract":"<p><strong>Background: </strong>Blood transfusion is the infusion of whole blood or its components into the veins of the patient to improve tissue oxygenation and maintain hemostasis. Besides its clinical use, it can pose a risk of transfusion complications with different factors.</p><p><strong>Purpose: </strong>The aim of this study was to assess blood transfusion complications, and associated factors among transfused adult patients at Tertiary care Hospital, Hyderabad, 2022.</p><p><strong>Materials and methods: </strong>An institution-based cross-sectional study design was conducted on a total of 182 patients from March 20 to June 15, 2022. Patients were enrolled in the study using consecutive sampling method. The socio-demographic and clinical data were collected using a structured questionnaire and data extraction sheet, respectively. About 3 ml of anti-coagulated blood and 30 ml of urine samples were collected to assess transfusion complications. CBC and Coombs test were performed from blood and urinalysis from urine, respectively. Chi-square, Fisher's exact test, and binary logistic regression were done using SPSS version 25. P-values less than 0.05 are declared as statistically significant.</p><p><strong>Results: </strong>An acute transfusion reaction (ATR) was encountered in 12 (6.6%) patients. It was 4.13, 7.78 and 3.96 times more likely to occur among patients with a previous history of transfusion, abortion, and transfused blood stored for more than 20 days compared to their counterparts, respectively. In addition, the odds of developing ATR increase by 2.07 as the number of transfused blood units increases by 1 unit.</p><p><strong>Conclusion: </strong>The incidence of acute transfusion reactions was high. During transfusion, clinicians should closely monitor patients who had history of transfusion, abortion, transfused old blood and more than 1 unit.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240013"},"PeriodicalIF":0.0,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hepatitis C Virus Infection and ABO Blood Group Assessment: Tertiary Hospital Study in India. 丙型肝炎病毒感染与 ABO 血型评估:印度三级医院研究
Kavi Manasa, Gurudutta Pattnaik, Y Madhusudan Rao, SaratKumar Behera, Amulyaratna Behera

People with certain blood groups and Rh positive are more prone to infections transmitted by blood transfusion. The aim of this research was to survey the accompaniment of ABO Blood Group System and Rh type with infection to hepatitis C virus in India. This was a retrospective study in patients during October 2019-March2022 in India. The population of blood donors was tested for blood borne infections, including HCV. Logistic regression was used and collected data were analyzed using SPSS v.16.A total number of 901 people referred to the organization for donating blood during aforementioned years. Of these, 224 people had a history of hepatitis C disease, including 189 unmarried persons and the rest were married. 167 individuals were males and 57individuals were females. People who had viral diseases were comprised of 76 persons with negative Rh and 148positive persons with Rh.Future aims should include studies into blood groups and Rh types, according to the results of this study, in order to avoid the spread of blood-borne infections. Furthermore, further study is needed to establish the particular blood kinds that provide an elevated danger for classified donors.

某些血型和 Rh 阳性的人更容易通过输血感染疾病。本研究旨在调查印度 ABO 血型系统和 Rh 型与丙型肝炎病毒感染的伴随关系。这是一项回顾性研究,研究对象为 2019 年 10 月至 2022 年 3 月期间印度的患者。献血者人群接受了包括丙型肝炎病毒在内的血源性感染检测。研究采用逻辑回归法,并使用 SPSS v.16 对收集的数据进行分析。其中,224 人有丙型肝炎病史,包括 189 名未婚者,其余为已婚者。男性 167 人,女性 57 人。根据本研究的结果,未来的目标应包括对血型和 Rh 类型的研究,以避免血液传播感染。此外,还需要开展进一步研究,以确定哪些特定血型会增加献血者的危险性。
{"title":"Hepatitis C Virus Infection and ABO Blood Group Assessment: Tertiary Hospital Study in India.","authors":"Kavi Manasa, Gurudutta Pattnaik, Y Madhusudan Rao, SaratKumar Behera, Amulyaratna Behera","doi":"10.62958/j.cjap.2024.012","DOIUrl":"https://doi.org/10.62958/j.cjap.2024.012","url":null,"abstract":"<p><p>People with certain blood groups and Rh positive are more prone to infections transmitted by blood transfusion. The aim of this research was to survey the accompaniment of ABO Blood Group System and Rh type with infection to hepatitis C virus in India. This was a retrospective study in patients during October 2019-March2022 in India. The population of blood donors was tested for blood borne infections, including HCV. Logistic regression was used and collected data were analyzed using SPSS v.16.A total number of 901 people referred to the organization for donating blood during aforementioned years. Of these, 224 people had a history of hepatitis C disease, including 189 unmarried persons and the rest were married. 167 individuals were males and 57individuals were females. People who had viral diseases were comprised of 76 persons with negative Rh and 148positive persons with Rh.Future aims should include studies into blood groups and Rh types, according to the results of this study, in order to avoid the spread of blood-borne infections. Furthermore, further study is needed to establish the particular blood kinds that provide an elevated danger for classified donors.</p>","PeriodicalId":23985,"journal":{"name":"Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology","volume":"40 ","pages":"e20240012"},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141634728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1